Graham Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50,506
Closed -$706K 1122
2023
Q4
$706K Buy
50,506
+40,052
+383% +$556K 0.02% 485
2023
Q3
$154K Buy
+10,454
New +$147K ﹤0.01% 897
2022
Q1
Sell
-29,193
Closed -$410K 917
2021
Q4
$410K Buy
+29,193
New +$480K 0.02% 221

Other funds holding DVAX

Graham Capital Management's DVAX Position: Q1 2024 in Review

Graham Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 50,506 shares — an estimated $706K sold.

Graham Capital Management first reported a position in DVAX in Q4 2021 and held it in 3 quarters. The position peaked at $706K in Q4 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Graham Capital Management reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • Graham Capital Management sold 50,506 Dynavax Technologies shares in Q1 2024, an estimated $706K.
  • Graham Capital Management first reported a position in Dynavax Technologies in Q4 2021 and held it in 3 quarters.
  • Graham Capital Management's Dynavax Technologies position peaked at $706K in Q4 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Graham Capital Management's 13F filing for Q1 2024, filed 15 May 2024.